Affected Systems |
|
|
|
|
|
behavior/neurological
|
N
|
|
√
|
|
behavior/neurological phenotype
|
N
|
|
|
|
lethargy
|
|
|
√
|
|
cardiovascular system
|
√
|
√
|
√
|
√
|
increased cardiac muscle glycogen level
|
|
√
|
|
|
abnormal myocardial fiber morphology
|
|
√
|
|
√
|
increased myocardial fiber size
|
√
|
|
|
|
myocardial fiber disarray
|
√
|
|
|
|
myocardium necrosis
|
|
|
√
|
|
cardiac muscle degeneration
|
|
|
√
|
|
abnormal heart atrium morphology
|
|
√
|
|
|
increased heart atrium size
|
|
√
|
|
|
increased heart left atrium size
|
|
√
|
|
|
enlarged heart
|
√
|
|
√
|
|
increased heart weight
|
|
|
√
|
|
cardiac hypertrophy
|
√
|
|
|
√
|
abnormal heart ventricle morphology
|
|
√
|
|
|
abnormal heart left ventricle morphology
|
|
|
√
|
√
|
heart left ventricle outflow tract stenosis
|
√
|
|
|
|
dilated heart left ventricle
|
|
|
√
|
√
|
increased heart ventricle size
|
|
√
|
|
|
thick ventricular wall
|
√
|
|
|
|
dilated heart right ventricle
|
|
|
|
√
|
cardiac fibrosis
|
|
√
|
|
|
cardiac interstitial fibrosis
|
√
|
|
|
|
abnormal cardiovascular system physiology
|
√
|
|
|
|
decreased cardiac muscle contractility
|
|
|
√
|
√
|
decreased heart left ventricle muscle contractility
|
|
√
|
|
|
increased cardiac muscle contractility
|
√
|
|
|
|
increased heart left ventricle muscle contractility
|
√
|
|
|
|
abnormal cardiac muscle relaxation
|
√
|
|
|
|
decreased heart rate
|
|
|
|
√
|
increased heart rate
|
|
|
|
√
|
ventricular tachycardia
|
|
√
|
|
|
atrial fibrillation
|
|
√
|
|
|
ventricular premature beat
|
|
√
|
|
|
prolonged PR interval
|
|
|
√
|
|
prolonged QRS complex duration
|
|
|
√
|
|
prolonged QT interval
|
|
√
|
|
|
abnormal myocardial fiber currents
|
|
√
|
|
|
abnormal myocardial fiber sodium currents
|
|
√
|
|
|
cardiomyopathy
|
√
|
√
|
|
√
|
dilated cardiomyopathy
|
|
|
√
|
|
cellular
|
√
|
|
|
√
|
cardiac interstitial fibrosis
|
√
|
|
|
|
abnormal mitochondrial morphology
|
|
|
|
√
|
increased mitochondrial fission
|
|
|
|
√
|
growth/size/body
|
√
|
|
√
|
√
|
enlarged heart
|
√
|
|
√
|
|
increased heart weight
|
|
|
√
|
|
cardiac hypertrophy
|
√
|
|
|
√
|
homeostasis/metabolism
|
|
√
|
|
|
increased cardiac muscle glycogen level
|
|
√
|
|
|
mortality/aging
|
|
|
√
|
|
prenatal lethality
|
|
|
√
|
|
muscle
|
√
|
√
|
√
|
√
|
increased cardiac muscle glycogen level
|
|
√
|
|
|
abnormal myocardial fiber morphology
|
|
√
|
|
√
|
increased myocardial fiber size
|
√
|
|
|
|
myocardial fiber disarray
|
√
|
|
|
|
myocardium necrosis
|
|
|
√
|
|
cardiac muscle degeneration
|
|
|
√
|
|
decreased cardiac muscle contractility
|
|
|
√
|
√
|
decreased heart left ventricle muscle contractility
|
|
√
|
|
|
increased cardiac muscle contractility
|
√
|
|
|
|
increased heart left ventricle muscle contractility
|
√
|
|
|
|
abnormal cardiac muscle relaxation
|
√
|
|
|
|
cardiomyopathy
|
√
|
√
|
|
√
|
dilated cardiomyopathy
|
|
|
√
|
|